These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26153451)

  • 1. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
    Ju MS; Na JH; Yu YG; Kim JY; Jeong C; Jung ST
    Mol Immunol; 2015 Oct; 67(2 Pt B):350-6. PubMed ID: 26153451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.
    Jung ST; Reddy ST; Kang TH; Borrok MJ; Sandlie I; Tucker PW; Georgiou G
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):604-9. PubMed ID: 20080725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies.
    Yoon HW; Jo M; Ko S; Kwon HS; Lim CS; Ko BJ; Lee JC; Jung ST
    Mol Immunol; 2019 Oct; 114():62-71. PubMed ID: 31336250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sugar removal on the structure of the Fc region of an IgG antibody as observed with single molecule Förster Resonance Energy Transfer.
    Kelliher MT; Jacks RD; Piraino MS; Southern CA
    Mol Immunol; 2014 Aug; 60(2):103-8. PubMed ID: 24813166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single molecule Förster resonance energy transfer studies of the effect of EndoS deglycosylation on the structure of IgG.
    Piraino MS; Kelliher MT; Aburas J; Southern CA
    Immunol Lett; 2015 Sep; 167(1):29-33. PubMed ID: 26112419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1.
    Nesspor TC; Raju TS; Chin CN; Vafa O; Brezski RJ
    J Mol Recognit; 2012 Mar; 25(3):147-54. PubMed ID: 22407978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAs.
    Chen TF; Sazinsky SL; Houde D; DiLillo DJ; Bird J; Li KK; Cheng GT; Qiu H; Engen JR; Ravetch JV; Wittrup KD
    J Mol Biol; 2017 Aug; 429(16):2528-2541. PubMed ID: 28694069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.
    Mimoto F; Kadono S; Katada H; Igawa T; Kamikawa T; Hattori K
    Mol Immunol; 2014 Mar; 58(1):132-8. PubMed ID: 24334029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
    Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
    J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance.
    Jo M; Kwon HS; Lee KH; Lee JC; Jung ST
    MAbs; 2018; 10(2):278-289. PubMed ID: 29173039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
    Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
    Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions.
    Schlothauer T; Herter S; Koller CF; Grau-Richards S; Steinhart V; Spick C; Kubbies M; Klein C; Umaña P; Mössner E
    Protein Eng Des Sel; 2016 Oct; 29(10):457-466. PubMed ID: 27578889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational and Colloidal Stabilities of Human Immunoglobulin G Fc and Its Cyclized Variant: Independent and Compensatory Participation of Domains in Aggregation of Multidomain Proteins.
    Yageta S; Shibuya R; Imamura H; Honda S
    Mol Pharm; 2017 Mar; 14(3):699-711. PubMed ID: 28186764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.
    Arduin E; Arora S; Bamert PR; Kuiper T; Popp S; Geisse S; Grau R; Calzascia T; Zenke G; Kovarik J
    Mol Immunol; 2015 Feb; 63(2):456-63. PubMed ID: 25451975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.